Table 2.
BPND in CD patients and controls in volumes of interest (VOIs).
| CD (n = 14) | Controls (n = 12) | |
|---|---|---|
| Frontal cortex | 0.33 ± 0.07 | 0.36 ± 0.06 |
| Anterior cingulate cortex | 0.43 ± 0.08 | 0.47 ± 0.09 |
| Thalamus | 1.24 ± 0.24 | 1.31 ± 0.22 |
| Caudate nucleus | 0.90 ± 0.37 | 0.89 ± 0.33 |
| Pallidum | 1.39 ± 0.30 | 1.51 ± 0.27 |
| Putamen | 1.57 ± 0.29 | 1.73 ± 0.27 |
| S. Nigra | 1.96 ± 0.66 | 1.82 ± 0.21 |
| Temporal lobe | 0.22 ± 0.06 | 0.22 ± 0.05 |
| Hippocampus | 0.49 ± 0.08 | 0.54 ± 0.09 |
| Amygdala | 1.58 ± 0.38 | 1.65 ± 0.34 |
| Insula | 0.62 ± 0.11 | 0.68 ± 0.11 |
| dRN | ||
| – dRNa | 5.29 ± 1.32 | 4.79 ± 1.84 |
| – dRNs | 6.78 ± 1.62 | 5.54 ± 3.42 |
| mRN | ||
| – mRNa | 9.67 ± 5.08 | 6.78 ± 2.28 |
| – mRNs | 10.02 ± 4.76 | 7.43 ± 1.72 |
The BPND of the different volumes of interest in CD patients and controls. No significant differences were detected. Data are shown as mean ± SD. CD, cervical dystonia; BPND, binding potential, non-displaceable; dRN, dorsal raphe nucleus, atlas based (dRNa) or subject based (dRNs); mRN, median raphe nucleus, atlas based (mRNa) or subject based (mRNs).